Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
19 February 2010
IN THIS ISSUE
Personalized medicine boost
H1N1 information sharing
PTE February
Anticancer nanodrugs
More...

A boost for personalized medicine
A joint investment of approximately 28 million Euros for seven projects hopes to bring personalized medicine closer to reality by developing ways of delivering drugs to specific disease sites within the human body. More...

EMA and Swissmedic to share H1N1 medicines information
The European Medicines Agency (EMA) and the Swiss Agency for Therapeutic Products, Swissmedic, have agreed to exchange information about the authorization and safety of H1N1 pandemic medicines. More...

Read the latest issue of PTE online
The February issue of Pharmaceutical Technology Europe includes a special feature on biopharmaceuticals, as well as articles on applying QbD principles to analytical measurements and patent protection. More...

Russian groups agree to produce anticancer nanodrugs
RUSNANO, a corporation established by the Russian government to foster the development of nanotechnology, has entered into a project to manufacture targeted-delivery nanodrugs to treat malignant neoplasms. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile
Sanderson Weatherall
  Processing equipment auction and sale

Due to re-organisation of stock levels, a pharmaceutical manufacturer is offering stainless steel vessels and stock of unused engineering spares to the process industry for auction.
South Dublin City, Ireland
Bidding closes: 2pm Thursday 25 February 2010
Read more...

Event Profile
Chemspec 2010
 


June 9-10
Messe Berlin, Germany


After the success of Chemspec Europe in Barcelona, Berlin is a natural choice as the destination for Chemspec Europe 2010. Germany is at the heart of the European fine and speciality chemicals market and the third largest chemical producer in the world making it an ideal destination for Chemspec Europe to celebrate its 25th anniversary. Read more...

CPhI/ICSE/P-MEC Japan 2010
  21 – 23 April 2010
Tokyo Big Sight Exhibition Centre
Japan

CPhl Japan 2010 is the country's leading pharma event and will provide European pharmaceutical companies with an excellent opportunity to get a foothold in the world’s second largest market…
Read more...

Podcast
Vetter Development Service Chicago
 


Peter Soelkner
Managing Director, Vetter Pharma International GmbH


Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc.
Read more...

Key Topic Updates
Latest blog posts
UK suffers medicines shortage
NSF, Microsoft Team in Cloud Computing
Keep an eye on that cargo
More blog posts

March events
IMHX (2–5 March | UK)
BIO-Europe Spring 2010 (8–10 March | Spain)
The Pharma Congress (9–10 March | Germany)
More events
 
Latest articles
Multivariate data analysis easily retrieves insight from a wealth of data
Trends and challenges of biopharma manufacturing
EU pricing dilemmas
More latest articles
 

Key Topic Updates



Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of APIs?
  The global economic recovery 37%
  The US economic recovery 14%
  Improved credit and financing flow to the small to emerging pharma/bio sector 14%
  Less restrictive inventory control by pharmaceutical companies 6%
  The level of competition from contract manufacturers in emerging markets 29%

This week we would like to know...

FDA increased its budget by 19% between FY 2009 and FY 2010, and has asked for another 23% increase for FY 2011. Has the agency asked for too much or too little?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.